Sunday, November 1, 2026

USD/EUR Bullish Momentum: 0.98% Up In The Last 10 Sessions

ViaNews Editorial Team

February 9, 2023

USD/EUR Bullish Momentum: 0.98% Up In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.98% for the last 10 sessions. At 09:11 EST on Thursday, 9 February, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 6.54% up from its 52-week low and 11.572% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.15%, a negative 0.09%, and a positive 0.52%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.42% (last month), and 0.52% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd: long-term trend remains tilted to the upside – socgen. According to FXStreet on Tuesday, 7 February, "The rally in EUR/USD came to a shuddering halt after the dovish market interpretation of the ECB rate decision. ", "The longer-term trend for EUR/USD remains tilted to the upside thanks to the improved terms of trade, the boost in economic growth in China, narrowing of Fed/ECB policy spread and attractive valuation."
  • Eur/usd stabilizes above 1.0700 despite fed’s powell confirming further policy tightening. According to FXStreet on Tuesday, 7 February, "The EUR/USD pair has shifted its auction profile above the round-level resistance of 1.0700 in the early Asian session. "
  • Eur/usd extends the decline and pierces 1.0700. According to FXStreet on Tuesday, 7 February, "Sellers remain well in control of the sentiment in the global markets and now drag EUR/USD briefly to the sub-1.0700 region on Tuesday.", "The steep sell-off in EUR/USD post-US NFP remains unabated on Tuesday and drags the pair to briefly test multi-week lows in the sub-1.0700 zone."
  • Eur/usd price analysis: mildly bid between five-week-old horizontal support and 200-sma. According to FXStreet on Tuesday, 7 February, "Even if the quote stays firmer past 1.0765 SMA hurdle, a downward-sloping resistance line from the last Thursday, around 1.0830 at the latest, could act as the last defense of the EUR/USD bears.", "Meanwhile, multiple levels marked since late December 2022, around 1.0710, challenge the EUR/USD bears. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com